查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1829337

2025年全球止血產品市場報告

Hemostasis Products Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，止血產品市場規模強勁成長，從2024年的17億美元增加至2025年的18億美元，複合年成長率為5.8%。預測期內的成長歸因於外科手術的增加、人口老化、血友病患病率的上升、醫療基礎設施的擴展以及人們對血液凝固障礙認知的不斷提高。

預計未來幾年止血產品市場規模將強勁成長，到2029年將達到23.3億美元，複合年成長率為6.7%。預測期內的成長可歸因於微創手術需求的不斷成長、全球創傷病例的增加、止血在慢性病中的應用不斷拓展、向門診手術中心的轉變、個性化醫療以及生物標記研究。預測期內的主要趨勢包括止血創新、止血技術的進步、對微創手術的日益偏好、慢性病盛行率的上升以及對可生物分解止血劑的關注。

止血產品是指在各種醫療環境中用於控制出血和促進凝血（止血）的醫療物質或器械。這些產品在治療出血性疾病、促進創傷治療以及確保人體凝血機制正常運作方面發揮重要作用。

止血產品主要分為外用止血產品、注射止血產品及高級止血產品。局部止血產品包括專門用於止血或控制出血的醫療物質和材料。它們用於各種場合，包括創傷、外科手術、血友病和心肌梗死，醫院和診所是主要的最終用戶。

2025年春季美國關稅的突然上調及其引發的貿易摩擦對醫療設備行業產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰使情況更加複雜，因為由於關稅而更換供應商通常需要重新認證醫療設備，導致市場進入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告是商業研究公司 (The Business Research Company) 新報告系列的一部分，該系列提供止血產品市場統計數據，例如全球市場規模、區域佔有率、止血產品市場佔有率的競爭對手、詳細的止血產品細分市場、市場趨勢和機遇，以及在止血產品行業取得成功所需的數據。本止血產品市場研究報告對該行業的現狀和未來趨勢進行了詳細分析，為您提供所需的一切觀點。

我們預測未來五年該市場將成長6.7%，較我們先前對該市場的預測略有下降0.4%。下降主要源自於美國與其他國家之間關稅的影響。這可能會透過對來自日本和以色列等主要地區的纖維蛋白膠施用器和可吸收止血紗布徵收關稅直接影響美國，從而導致外科止血面臨挑戰，並增加創傷和外科手術的成本。由於互惠關稅以及貿易緊張局勢和限制加劇對全球經濟和貿易的負面影響，這種影響也將更加廣泛地顯現。

血液疾病盛行率的不斷上升預計將在未來幾年推動止血產品市場的成長。血液疾病，也稱為血液學疾病，涵蓋了影響血液及其成分的組成、功能和行為的各種醫療狀況。止血產品有助於管理體內的凝血和出血過程，並用於治療各種血液疾病，以解決各種血液疾病中可能發生的過度出血（出血）和過度凝血（血栓症）。例如，美國白血病和淋巴瘤協會在 2022 年報告稱，美國白血病的診斷率從 2021 年的每 10 萬名公民 14.1 例上升到 2022 年的 14.3 例。因此，血液疾病盛行率的不斷上升正在推動止血產品市場的成長。

心臟病患病率的不斷上升預計將推動止血產品市場的成長。心臟病包括各種影響心臟和血管的疾病。止血產品在控制、預防和治療與心臟病相關的出血方面發揮重要作用。這些產品可以最大限度地減少出血，從而減少輸血需求並減少與心臟病相關的併發症。例如，2024年1月，美國非營利組織美國心臟協會報告稱，到2024年，心血管疾病的年齡調整死亡率將上升至每10萬人233.3人，比2023年的每10萬人224.4人增加4.0%。因此，心臟疾病率的不斷上升將有助於未來止血產品市場的成長。

止血產品市場的主要企業正致力於開發創新藥物，包括 NexPowder 內視鏡止血系統，並已獲得核准用於控制出血的全面主動和被動止血產品組合。內視鏡止血系統是一種內視鏡檢查過程中控制胃腸道出血的醫療設備和技術。 2022 年 9 月，美國醫療設備製造商Medtronic的 NexPowder 內視鏡止血系統獲得美國食品藥物管理局的核准，該系統旨在治療非竇性上消化道出血。這種創新的止血材料由於其易用性、有效性和良好的耐受性，有可能對非竇性上消化道出血的治療產生重大影響。

2022年3月，美國專業醫療設備公司C2Dx Inc.收購了Hemostatix Medical Technologies LLC，收購金額未揭露。此次收購支持了C2Dx投資並強化其高價值利基產品供應的策略，並將促進C2Dx品牌下熱感刀系統的整合。 Hemostatix Medical Technologies LLC也是美國醫療科技公司。

止血產品市場的關鍵參與企業包括輝瑞公司、雅培實驗室、賽默飛世爾科技公司、美敦力公司、強生私人有限公司、西門子醫療公司、碧迪公司 (BD)、史賽克公司、百特國際公司、波士頓科學公司、羅氏公司、Braun Melsungen AG、費森尤卡比、邁林邦美控股公司、邁林邦美控股公司、奧林邦美林 SA Inc.、全錄輝公司、愛惜康縫合實驗室、Hologic Inc.、庫克醫療公司、泰利福公司、Integra LifeSciences Corporation、Haemonetics Corporation、Z-Medica LLC、Tricol Biomedical、Hem Con Medical Technologies Inc.、Hemostasis LLC、CR Bard Inc. 和 CuraMedical BV。

2024年，北美是止血產品市場最大的地區。預計亞太地區將成為預測期內成長最快的地區。止血產品市場報告涵蓋的地區包括亞太地區、西歐、東歐、北美、南美、中東和非洲。

止血產品市場報告涵蓋的國家：澳洲、巴西、中國、法國、德國、印度、印尼、日本、俄羅斯、韓國、英國、美國、加拿大、義大利、西班牙

止血產品市場包括止血劑、止血粉、止血海綿、膠原膠原蛋白、氧化再生纖維素、明膠、多醣、流體複合物、凝血酶複合物、纖維蛋白複合物、合成封閉劑和新鮮冷凍血漿的銷售。該市場的價值為“出廠價”，即商品製造商或生產商向其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接向最終客戶銷售的商品價值。該市場中的商品價值還包括商品製造商提供的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球止血產品：PESTEL分析（政治、社會、科技、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球止血產品市場：成長率分析
  • 全球止血產品市場表現：規模與成長，2019-2024
  • 全球止血產品市場預測：2024-2029年、2034年規模與成長
  • 全球止血產品：總目標市場（TAM）

第6章 市場細分

  • 全球止血產品市場：按產品、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 局部止血劑
  • 輸液止血劑
  • 先進的止血產品
  • 全球止血產品市場應用、性能及預測（2019-2024、2024-2029、2034）
  • 創傷
  • 外科手術
  • 血友病
  • 心肌梗塞
  • 其他
  • 全球止血產品市場（按最終用戶、績效和預測），2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 診所
  • 其他
  • 全球止血產品市場：局部止血劑細分，按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 止血劑
  • 組織密封膠
  • 纖維蛋白膠
  • 全球止血產品市場：輸液止血劑細分、類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 富血小板血漿（platelet-rich plasma）
  • 凝血因子
  • 凝血酶原複合物濃縮物
  • 全球止血產品市場：先進止血產品細分市場，按類型、性能和預測，2019-2024 年、2024-2029 年、2034 年
  • 生物黏合劑
  • 合成止血劑
  • 止血敷料

第7章 區域和國家分析

  • 全球止血產品市場：區域表現與預測，2019-2024 年、2024-2029 年、2034 年
  • 全球止血產品市場：依國家、績效及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 止血產品市場：競爭格局
  • 止血產品市場：公司簡介
    • Pfizer Inc.
    • Abbott Laboratories
    • Thermo Fisher Scientific Inc.
    • Medtronic plc
    • Johnson And Johnson Pvt. Ltd.

第31章：其他領先和創新企業

  • Siemens Healthineers
  • Becton Dickinson and Company（BD）
  • Stryker Corporation
  • Baxter International Inc.
  • Boston Scientific Corporation
  • F. Hoffmann-La Roche Ltd.
  • BBraun Melsungen AG
  • Fresenius Kabi AG
  • Zimmer Biomet Holdings Inc.
  • Olympus Corporation
  • Grifols SA
  • Terumo BCT Inc.
  • Smith And Nephew plc
  • Ethicon Suture Laboratories
  • Hologic Inc.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第35章：市場潛力大的國家與策略

  • 2029 年止血產品市場：提供新機會的國家
  • 2029 年止血產品市場：細分市場帶來新機會
  • 2029 年止血產品市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r28242u

Hemostasis products are medical substances or devices employed to control bleeding and facilitate clotting (hemostasis) across diverse medical contexts. These products play a critical role in the management of bleeding disorders, promotion of wound healing, and ensuring the proper functioning of the body's clotting mechanisms.

The primary categories of hemostasis products include topical hemostasis products, infusible hemostasis products, and advanced hemostasis products. Topical hemostasis products encompass medical substances or materials specifically designed to halt or regulate bleeding. They find applications in various scenarios such as trauma, surgery, hemophilia, myocardial infarction, and others, with major end-users including hospitals, clinics, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The hemostasis products market research report is one of a series of new reports from The Business Research Company that provides hemostasis products market statistics, including hemostasis products industry global market size, regional shares, competitors with a hemostasis products market share, detailed hemostasis products market segments, market trends and opportunities, and any further data you may need to thrive in the hemostasis products industry. This hemostasis products market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hemostasis products market size has grown strongly in recent years. It will grow from $1.7 billion in 2024 to $1.8 billion in 2025 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to rise in surgical procedures, growing aging population, increasing incidence of hemophilia, expanding healthcare infrastructure, rising awareness about blood clotting disorders.

The hemostasis products market size is expected to see strong growth in the next few years. It will grow to $2.33 billion in 2029 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to rising demand for minimally invasive surgeries, global increase in trauma cases, expansion of hemostasis applications in chronic diseases, shift towards ambulatory surgical centers, personalized medicine and biomarker research. Major trends in the forecast period include technological innovations in hemostasis, advancements in hemostatic technologies, rising preference for minimally invasive procedures, growing incidence of chronic diseases, focus on biodegradable hemostatic agents.

The forecast of 6.7% growth over the next five years reflects a modest reduction of 0.4% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on fibrin sealant applicators and absorbable hemostatic gauze, sourced from key regions such as Japan and Israel, which could lead to surgical bleeding control challenges and higher costs for trauma and surgical procedures.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The growing prevalence of blood disorders is anticipated to drive the growth of the hemostasis products market in the future. Blood disorders, also referred to as hematologic disorders, encompass a range of medical conditions that impact the composition, function, and behavior of blood and its components. Hemostasis products are utilized in various blood disorders to help manage the processes of clotting and bleeding in the body, addressing both excessive bleeding (hemorrhage) and excessive clotting (thrombosis) that can arise in different blood disorders. For example, in 2022, the Leukemia and Lymphoma Society, a U.S.-based organization, reported that the rate of leukemia diagnoses in the United States rose from 14.1 per 100,000 citizens in 2021 to 14.3 per 100,000 in 2022. Consequently, the increasing prevalence of blood disorders is fueling the growth of the hemostasis products market.

The rising prevalence of cardiac disorders is expected to propel the growth of the hemostasis products market moving forward. Cardiac disorders encompass a wide range of medical conditions and diseases that impact the heart and blood vessels. Hemostasis products play a critical role in managing bleeding related to cardiac disorders, as well as in their prevention and treatment. These products can help minimize blood loss, thereby reducing the need for blood transfusions and the associated complications in cardiac disorders. For instance, in January 2024, the American Heart Association, a U.S.-based non-profit organization, reported that the age-adjusted death rate from cardiovascular disease rose to 233.3 per 100,000 in 2024, reflecting a 4.0% increase from 224.4 per 100,000 in 2023. Therefore, the increasing prevalence of cardiac disorders is contributing to the growth of the hemostasis products market going forward.

Major companies in the hemostasis products market are focusing on the development of innovative drugs, including the Nexpowder endoscopic hemostasis system, and obtaining approvals for a comprehensive range of active and passive hemostatic products for bleeding control. The endoscopic hemostasis system is a medical device and technique used to control bleeding in the gastrointestinal (GI) tract during endoscopic procedures. Medtronic plc, a US-based medical device company, received clearance from the U.S. Food and Drug Administration in September 2022 for the Nexpowder Endoscopic Hemostasis System, designed for the treatment of nonvariceal upper GI bleeding. This innovative hemostatic product has the potential to make a significant impact on the treatment of nonvariceal upper GI bleeding due to its ease of use, effectiveness, and good tolerability.

In March 2022, C2Dx Inc., a U.S.-based specialty medical devices company, acquired Hemostatix Medical Technologies LLC for an undisclosed sum. This acquisition supports C2Dx's strategy to invest in and enhance the delivery of valuable niche products, facilitating the integration of the thermal scalpel system under the C2Dx brand. Hemostatix Medical Technologies LLC is also a U.S.-based medical technology company.

Major companies operating in the hemostasis products market report are Pfizer Inc., Abbott Laboratories, Thermo Fisher Scientific Inc., Medtronic PLC, Johnson And Johnson Pvt. Ltd., Siemens Healthineers, Becton Dickinson and Company (BD), Stryker Corporation, Baxter International Inc., Boston Scientific Corporation, F. Hoffmann-La Roche Ltd., BBraun Melsungen AG, Fresenius Kabi AG, Zimmer Biomet Holdings Inc., Olympus Corporation, Grifols S.A., Terumo BCT Inc., Smith And Nephew PLC, Ethicon Suture Laboratories, Hologic Inc., Cook Medical, Teleflex Incorporated, Integra LifeSciences Corporation, Haemonetics Corporation, Z-Medica LLC, Tricol Biomedical, Hem Con Medical Technologies Inc., Hemostasis LLC, C. R. Bard Inc., CuraMedical BV

North America was the largest region in the hemostasis products market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hemostasis products market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the hemostasis products market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The hemostasis products market consists of sales of hemostatic agents, hemostatic powders, hemostatic sponges, collagen, oxidized regenerated cellulose, gelatin, polysaccharide, flowable complex, thrombin complex, fibrin complex, synthetic sealants, and fresh frozen plasma. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Hemostasis Products Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hemostasis products market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for hemostasis products ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The hemostasis products market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Topical Hemostasis Product; Infusible Hemostasis Product; Advanced Hemostasis Product
  • 2) By Application: Trauma; Surgery; Hemophilia; Myocardial Infarction; Other Applications
  • 3) By End User: Hospitals; Clinics; Other End Users
  • Subsegments:
  • 1) By Topical Hemostasis Product: Hemostatic Agents; Tissue Sealants; Fibrin Sealants
  • 2) By Infusible Hemostasis Product: Platelet-Rich Plasma (PRP); Coagulation Factors; Prothrombin Complex Concentrates
  • 3) By Advanced Hemostasis Product: Biological Adhesives; Synthetic Hemostatic Agents; Hemostatic Dressings
  • Companies Mentioned: Pfizer Inc.; Abbott Laboratories; Thermo Fisher Scientific Inc.; Medtronic plc; Johnson And Johnson Pvt. Ltd.; Siemens Healthineers; Becton Dickinson and Company (BD); Stryker Corporation; Baxter International Inc.; Boston Scientific Corporation; F. Hoffmann-La Roche Ltd.; BBraun Melsungen AG; Fresenius Kabi AG; Zimmer Biomet Holdings Inc.; Olympus Corporation; Grifols S.A.; Terumo BCT Inc.; Smith And Nephew plc; Ethicon Suture Laboratories; Hologic Inc.; Cook Medical; Teleflex Incorporated; Integra LifeSciences Corporation; Haemonetics Corporation; Z-Medica LLC; Tricol Biomedical; Hem Con Medical Technologies Inc.; Hemostasis LLC; C. R. Bard Inc.; CuraMedical BV
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Hemostasis Products Market Characteristics

3. Hemostasis Products Market Trends And Strategies

4. Hemostasis Products Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Hemostasis Products Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Hemostasis Products PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Hemostasis Products Market Growth Rate Analysis
  • 5.4. Global Hemostasis Products Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Hemostasis Products Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Hemostasis Products Total Addressable Market (TAM)

6. Hemostasis Products Market Segmentation

  • 6.1. Global Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Topical Hemostasis Product
  • Infusible Hemostasis Product
  • Advanced Hemostasis Product
  • 6.2. Global Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Trauma
  • Surgery
  • Hemophilia
  • Myocardial Infarction
  • Other Applications
  • 6.3. Global Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Clinics
  • Other End Users
  • 6.4. Global Hemostasis Products Market, Sub-Segmentation Of Topical Hemostasis Product, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hemostatic Agents
  • Tissue Sealants
  • Fibrin Sealants
  • 6.5. Global Hemostasis Products Market, Sub-Segmentation Of Infusible Hemostasis Product, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Platelet-Rich Plasma (PRP)
  • Coagulation Factors
  • Prothrombin Complex Concentrates
  • 6.6. Global Hemostasis Products Market, Sub-Segmentation Of Advanced Hemostasis Product, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Biological Adhesives
  • Synthetic Hemostatic Agents
  • Hemostatic Dressings

7. Hemostasis Products Market Regional And Country Analysis

  • 7.1. Global Hemostasis Products Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Hemostasis Products Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Hemostasis Products Market

  • 8.1. Asia-Pacific Hemostasis Products Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Hemostasis Products Market

  • 9.1. China Hemostasis Products Market Overview
  • 9.2. China Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Hemostasis Products Market

  • 10.1. India Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Hemostasis Products Market

  • 11.1. Japan Hemostasis Products Market Overview
  • 11.2. Japan Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Hemostasis Products Market

  • 12.1. Australia Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Hemostasis Products Market

  • 13.1. Indonesia Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Hemostasis Products Market

  • 14.1. South Korea Hemostasis Products Market Overview
  • 14.2. South Korea Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Hemostasis Products Market

  • 15.1. Western Europe Hemostasis Products Market Overview
  • 15.2. Western Europe Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Hemostasis Products Market

  • 16.1. UK Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Hemostasis Products Market

  • 17.1. Germany Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Hemostasis Products Market

  • 18.1. France Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Hemostasis Products Market

  • 19.1. Italy Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Hemostasis Products Market

  • 20.1. Spain Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Hemostasis Products Market

  • 21.1. Eastern Europe Hemostasis Products Market Overview
  • 21.2. Eastern Europe Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Hemostasis Products Market

  • 22.1. Russia Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Hemostasis Products Market

  • 23.1. North America Hemostasis Products Market Overview
  • 23.2. North America Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Hemostasis Products Market

  • 24.1. USA Hemostasis Products Market Overview
  • 24.2. USA Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Hemostasis Products Market

  • 25.1. Canada Hemostasis Products Market Overview
  • 25.2. Canada Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Hemostasis Products Market

  • 26.1. South America Hemostasis Products Market Overview
  • 26.2. South America Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Hemostasis Products Market

  • 27.1. Brazil Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Hemostasis Products Market

  • 28.1. Middle East Hemostasis Products Market Overview
  • 28.2. Middle East Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Hemostasis Products Market

  • 29.1. Africa Hemostasis Products Market Overview
  • 29.2. Africa Hemostasis Products Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Hemostasis Products Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Hemostasis Products Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Hemostasis Products Market Competitive Landscape And Company Profiles

  • 30.1. Hemostasis Products Market Competitive Landscape
  • 30.2. Hemostasis Products Market Company Profiles
    • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Johnson And Johnson Pvt. Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Hemostasis Products Market Other Major And Innovative Companies

  • 31.1. Siemens Healthineers
  • 31.2. Becton Dickinson and Company (BD)
  • 31.3. Stryker Corporation
  • 31.4. Baxter International Inc.
  • 31.5. Boston Scientific Corporation
  • 31.6. F. Hoffmann-La Roche Ltd.
  • 31.7. BBraun Melsungen AG
  • 31.8. Fresenius Kabi AG
  • 31.9. Zimmer Biomet Holdings Inc.
  • 31.10. Olympus Corporation
  • 31.11. Grifols S.A.
  • 31.12. Terumo BCT Inc.
  • 31.13. Smith And Nephew plc
  • 31.14. Ethicon Suture Laboratories
  • 31.15. Hologic Inc.

32. Global Hemostasis Products Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Hemostasis Products Market

34. Recent Developments In The Hemostasis Products Market

35. Hemostasis Products Market High Potential Countries, Segments and Strategies

  • 35.1 Hemostasis Products Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Hemostasis Products Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Hemostasis Products Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer